News Call goes out for type 1 diabetes screening in UK A finger-prick screening programme for type 1 diabetes should roll out in the UK, say researchers, given a disease-modifying drug is now available.
News Sanofi seeks use of type 1 diabetes drug in younger kids Sanofi could be months away from wider US approval for Tzield, its drug for delaying the progression of type 1 diabetes, in children as young as one.
News Sanofi's type 1 diabetes drug poised for EU rollout Sanofi is celebrating an approval recommendation in the EU for Teizeild, a first-in-class drug designed to delay the progression of type 1 diabetes.
Patients World Diabetes Day: Type 1 diabetes in the spotlight and und... This World Diabetes Day, Sanofi UK and DigiBete are hosting a pop-up event in Leeds to spotlight type 1 diabetes and the need for early detection.
News 'Diabetes Barbie' launches with medtech accessories Barbie just took a step forward for inclusivity and representation with the launch of a doll with type 1 diabetes.
News ADA: Vertex closer to weaning type 1 diabetics off insulin A cell therapy developed by Vertex Pharma has allowed 10 of 12 patients with type 1 diabetes to control their blood sugar without insulin.
News GSK's RSV shot cleared in US for all adults GSK is back on level pegging with its rivals in the RSV vaccine category in the US, after getting FDA approval for Arexvy in the 18 to 49 age bracket.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.